Nanjing Aizhichao Technology Co., LTD – Trademark Portfolio

Entity Type: 99

Nanjing Aizhichao Technology Co., LTD holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include LNDOLL and EROVENUS. The owner is based in Nanjing.

Center, Yuhua Street, Yuhuatai District,

Rm 1105, Bldg G-5, Himalaya Commercial

Nanjing 210000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LNDOLL
LNDOLL
Registered 2024
EROVENUS
EROVENUS
Registered 2024

Trademark Classifications

Nanjing Aizhichao Technology Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Nanjing Aizhichao Technology Co., LTD have?

Nanjing Aizhichao Technology Co., LTD has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Nanjing Aizhichao Technology Co., LTD file in?

Nanjing Aizhichao Technology Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Nanjing Aizhichao Technology Co., LTD's most well-known trademarks?

Nanjing Aizhichao Technology Co., LTD's registered trademark portfolio includes well-known marks such as LNDOLL and EROVENUS. These are among 2 currently registered trademarks in the portfolio.

What is Nanjing Aizhichao Technology Co., LTD's trademark registration success rate?

Nanjing Aizhichao Technology Co., LTD has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.